Details for Patent: 6,030,643
✉ Email this page to a colleague
Summary for Patent: 6,030,643
Title: | Potassium, sodium and tris oxaprozin salt pharmaceutical formulations |
Abstract: | Pharmaceutical compositions containing potassium, sodium or Tris salt of oxaprozin as an active agent. The pharmaceutical compositions of the present invention are useful in eliminating or ameliorating pain and in the treatment of inflammation and inflammation associated disorders such as rheumatoid arthritis and osteoarthritis. |
Inventor(s): | Adams; Mark E. (Evergreen Park, IL), Desai; Subhash (Grayslake, IL), Karim; Aziz (Skokie, IL), Paul; Kalidas (Skokie, IL), Schaaf; Douglas J. (Elgin, IL), Zold; David J. (Prospect Heights, IL) |
Assignee: | G.D. Searle & Co. (Chicago, IL) |
Application Number: | 08/857,999 |
Patent Claim Types: see list of patent claims | Composition; Dosage form; Use; | More… ↓ |
Drugs Protected by US Patent 6,030,643
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,030,643
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 299699 | ⤷ Subscribe | |||
Australia | 3059797 | ⤷ Subscribe | |||
Australia | 718030 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |